BCG vaccine produce BCG. Along with supply availability from existing manufacturers, and a "new WHO prequalified vaccine" the total supply will be "sufficient to meet both suppressed 2015 demand carried over to 2016, as well as total forecast demand through 2016-2018." In the fall of 2011, the Sanofi Pasteur plant flooded causing problems with mold. The facility, located in Toronto, Ontario, Canada, produced BCG vaccine products, made with substrain Connaught, such as a tuberculosis vaccine ImmuCYST, a BCG Immunotherapeutic – a bladder cancer drug. By April 2012 the FDA had found dozens of documented problems with sterility at the plant including mold,
Abell 1201 BCG than expected from the usual scaling relations between black holes and host galaxies. However, alternative methods of modelling the stellar velocity dispersion maps reveals an ambiguity between the UMBH mass and the dark halo profile. In solutions where the UMBH is more massive, the dark matter is more cuspy. In solutions where the UMBH is smaller or absent, the dark matter is more cored. The dark halo's ellipticity and the mass-to-light ratio of stars also enter the ambiguity. Thus, if the standard computational models are robust, then Abell 1201 BCG presents a dilemma and a challenge to either the conventional